India's first indigenous biologic, Biocon's ALZUMAb gets approval for COVID-19 treatment
India's first indigenous biologic, Biocon's ALZUMAb gets approval for COVID-19 treatment: Following the news that India-based biopharma company Biocon’s plaque psoriasis drug itolizumab (ALZUMAb) has secured approval from the Drugs Controller General of India (DCGI) for emergency use in COVID-19 patients;
VARINDIA- INDIA'S FRONTLINE IT MAGAZINE
VARINDIA- INDIA'S FRONTLINE IT MAGAZINE
Comments
Post a Comment